DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million
COPENHAGEN, Denmark, November 3, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabinoids, hereby announce that the Company has signed a supply agreement (the “Agreement”) with Storkpharm Sp. z o.o. (“Storkpharm”) for the Polish market. The Agreement covers the period 2024 to 2025 (the “Period”), and furthermore 2026 to be discussed during the Period.Storkpharm is a private hold pharmaceutical wholesale company in Poland, approved by Polish health authorities and with a widespread distribution network in the country that includes